- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Psychological, Social Issues Dr Brian Vickery Sees With His Patients With Food Allergies
Despite a patient's vigilance, there is an unpredictable risk of an accidental reaction from an exposure, explained Brian Vickery, MD, associate professor of pediatrics at Emory University and director of the Food Allergy Center, Children’s Healthcare of Atlanta.
Despite a patient's vigilance, there is an unpredictable risk of an accidental reaction from an exposure, explained Brian Vickery, MD, associate professor of pediatrics at Emory University and director of the Food Allergy Center, Children’s Healthcare of Atlanta.
Transcript
What are some psychological and social issues your patients with food allergies cope with?
The burdens of eliminating these foods from their diet is difficult but can be managed. I think the main thing is that there is an unpredictable risk of an accidental reaction from an exposure despite their vigilance, and we know that from longitudinal studies. It is simple to say, “just avoid the food and you’ll be fine.” In practice, it’s really difficult to do that, and that means that patients are at risk. They typically eat 3-5 times a day, and they are at an unpredictable risk for a potentially life-threatening situation, and that risk is compounded by the fact that they themselves must evaluate the situation and administer a rescue medication, get them to the hospital if they need to, and basically act as a first responder to keep themselves safe. That’s a tremendous burden to carry around. It’s a tremendous stress. I think people are really concerned about the possibility of a life-threatening situation developing, and this is what we consistently hear over and over from patients.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More
